Found 4 matching trials
A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
PHASE2This clinical trial will be a multicenter phase II fixed-dose trial in whic...
Location
Albert Einstein Cancer Center at Albert Einstein College of Medicine
RFT5-dgA Immunotoxin in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma
PHASE2RATIONALE: Immunotoxins, such as RFT5-dgA immunotoxin (also called anti-CD2...
Location
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
RFT-5-dgA in Patients With Metastatic Melanoma
PHASE2Background:
* CD4+ cells are white blood cells that regulate the immune sy...
Location
National Cancer Institute (NCI)
Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS
PHASE2This study will evaluate the safety and effectiveness of stem cell transpla...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike